Ocumetics completes manufacturing of next-generation intraocular lens for Group Two first-in-human trial in Mexico City

• Ocumetics completed manufacturing of its next-generation solid-state accommodating intraocular lens for Group Two first-in-human surgeries in Mexico City.
• Clinical lenses are scheduled to ship from Germany in early September, with patient recruitment set to begin shortly.
• Results have not been presented; the upcoming surgeries are intended to generate additional human clinical data on the redesigned lens.
• The new one-piece design targets better accommodative performance, easier surgical handling, improved long-term reliability, lower manufacturing complexity.
• Group One patients are nearing 12-month follow-up visits, adding longer-term clinical evidence alongside the new Group Two data.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocumetics Technology Corp. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202608310900TNWSWRCACNPR_____1LpMFYNm8) on August 31, 2026, and is solely responsible for the information contained therein.